Treatment of severe postmenopausal endometriosis with an aromatase inhibitor

Fertility and Sterility

Volumn 69, Issue 4, 1998, Pages 709-713

  Takayama, Kazuto ^a   Zeitoun, Khaled ^a   Gunby, Robert T ^b   Sasano, Hironobu ^c   Carr, Bruce R ^a   Bulun, Serdar E ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b Baylor University   (United States)

^c TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Alendronate; Anastrozole; Aromatase; Aromatase inhibitors; Bisphosphonates; Endometriosis; Estrogen biosynthesis; Osteoporosis

Indexed keywords

ALENDRONIC ACID; ANASTROZOLE; AROMATASE; AROMATASE INHIBITOR; ESTRADIOL; FOLLITROPIN;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CLINICAL TRIAL; DRUG EFFICACY; ENDOMETRIOSIS; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; HUMAN; ORAL DRUG ADMINISTRATION; OSTEOPOROSIS; PATHOPHYSIOLOGY; POSTMENOPAUSE; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ANIMALS; AROMATASE; AROMATASE INHIBITORS; BIOPSY; ENDOMETRIOSIS; ENZYME INHIBITORS; FEMALE; HUMANS; MIDDLE AGED; NITRILES; POLYMERASE CHAIN REACTION; POSTMENOPAUSE; RATS; RECURRENCE; RNA, MESSENGER; TIME FACTORS; TRIAZOLES;

EID: 0031956139     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(98)00022-3     Document Type: Article

References (15)

1. Henzl MR, Corson SL, Moghissi K, Buttram VC, Berqvist C, Jacobson J. Administration of nasal nafarelin as compared with oral danazol for endometriosis. N Engl J Med. 318:1988;485-489.
2. Waller KG, Shaw RW. Gonadotropin-releasing hormone analogues for the treatment of endometriosis long-term follow-up . Fertil Steril. 59:1993;511-515.
3. Simpson ER, Mahendroo MS, Means GD, Kilgore MW, Hinshelwood MM, Graham-Lorence S, et al. Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. Endocr Rev. 15:1994;342-355.
4. Agarwal VR, Bulun SE, Leitch M, Rohrich R, Simpson ER. Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients. J Clin Endocrinol Metab. 81:1996;3843-3849.
5. Bulun SE, Price TM, Mahendroo MS, Aitken J, Simpson ER. A link between breast cancer and local estrogen biosynthesis suggested by quantification of breast adipose tissue aromatase cytochrome P450 transcripts using competitive polymerase chain reaction after reverse transcription. J Clin Endocrinol Metab. 77:1993;1622-1628.
6. Agarwal VR, Ashanullah CI, Simpson ER, Bulun SE. Alternatively spliced transcripts of the aromatase cytochrome P450 (CYP19) gene in adipose tissue of women. J Clin Endocrinol Metab. 82:1996;70-74.
7. Santen RJ. Estrogen synthesis inhibitors: from "off the rack" to "Haute Couture." J Clin Endocrinol Metab. 77:1993;316-318.
8. Noble LS, Simpson ER, Johns A, Bulun SE. Aromatase expression in endometriosis. J Clin Endocrinol Metab. 81:1996;174-179.
9. 2 stimulates aromatase expression in endometriosis-derived stromal cells. J Clin Endocrinol Metab. 82:1997;600-606.
10. Devogelaer JP, Broll H, Correa-Rotter R, Cumming DC, De Deuxchaisnes CN, Geusens P, et al. Oral alendronate induces progressive increases in bone mass of the spine, hip, and total body over 3 years in postmenopausal women with osteoporosis. Bone. 18:1996;141-150.
11. Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MD, et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures fracture intervention trial research group . Lancet. 348:1996;1535-1541.
12. Bulun SE, Simpson ER. Competitive RT-PCR analysis indicates levels of aromatase cytochrome P450 transcripts in adipose tissue of buttocks, thighs, and abdomen of women increase with advancing age. J Clin Endocrinol Metab. 78:1994;428-432.
13. Huang JC, Dawood MY, Wu KK. Regulation of cyclooxygenase-2 gene in cultured endometrial stromal cells by sex steroids [abstract]. Am Soc Reprod Med. 5S:1996.
14. Surrey ES, Voigt B, Fournet N, Judd HL. Prolonged gonadotropin-releasing hormone agonist treatment of symptomatic endometriosis the role of cyclic sodium etidronate and low-dose norethindrone "add-back" therapy . Fertil Steril. 63:1995;747-755.
15. Zeitoun KM, Takayama K, Moghrabi N, Putman M, Carr BR, Bulun SE, et al. Conversion of estrone to estradiol is increased in endometriosis compared with the endometrium [abstract]. J Soc Gynecol Invest. 4:1997;239A.